Glioblastoma is a brain cancer with very poor survival outcomes. Most drugs can't cross the blood-brain barrier, which means ...

Three-dimensional bioprinted tissues composed of cells and other body-compatible materials have emerged as a powerful tool to repair damaged heart tissue. However, most bioprinted tissues cannot ...

Proceeds from the Series B enable Aspect to advance multiple bioprinted tissue therapeutics towards the clinic with a mission to deliver a new class of cellular medicines and functional cures for ...

VANCOUVER, British Columbia — Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics as a new category in regenerative medicine, today announced that ...

Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics as a new category in regenerative medicine, today announced that it has closed a US$115 ...